Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Chris Cooper
JPM
Chris Cooper
J.P. Morgan
Wall Street Analyst
★★★★☆
#483
on 13Foresight · ranked by our own returns
82%
Success Rate
+9.4%
Average Return
9 of 11 calls profitable · -11.0% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 82% of Chris Cooper's ratings turned a profit when each position was held for 1 year — averaging +9.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

4 Buy 1 Hold 0 Sell
Chris's Stock Coverage 27 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
AU:PME
Pro Medicus Limited
 May 18, 2026 BUY Strong Buy
+52.9% avg upside
7 analysts
$207.90
24.70% Upside
 ·
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
 May 04, 2026 BUY Strong Buy
+58.0% avg upside
11 analysts
$37.10
38.87% Upside
 ·
AU:COH
Cochlear
Apr 24, 2026 HOLD Hold
+51.8% avg upside
15 analysts
$111.00
2.57% Downside
 ·
RMD
Resmed
 Apr 15, 2026 BUY Buy
+25.4% avg upside
27 analysts
 — -15.3%
AU:NAN
Nanosonics Limited
 Jan 24, 2024 SELL Hold
+45.1% avg upside
7 analysts
$3.00
7.72% Downside
 ·
AU:SHL
Sonic Healthcare Limited
 Jan 24, 2024 HOLD Buy
+30.8% avg upside
12 analysts
$29.70
48.07% Upside
 ·
AU:HLS
Healius Limited
 Jan 24, 2024 HOLD Sell
+109.7% avg upside
10 analysts
$1.40
244.06% Upside
 ·
AU:CSL
CSL
 Dec 04, 2023 BUY Strong Buy
+63.9% avg upside
15 analysts
$309.00
177.52% Upside
 ·
AU:OPT
Opthea
Oct 15, 2023 BUY Buy
+2169.5% avg upside
4 analysts
$2.05
241.71% Upside
 ·
AU:RHC
Ramsay Health Care
 Aug 24, 2023 SELL Hold
+1.7% avg upside
14 analysts
$43.00
9.70% Upside
 ·
CSL
Carlisle Companies
 Aug 15, 2023 HOLD Buy
+2.4% avg upside
15 analysts
$296.00
17.98% Downside
 +45.8%
ARCT
Arcturus Therapeutics
 Apr 28, 2023 SELL Buy
+291.8% avg upside
35 analysts
 — +0.3%
AU:ACL
Australian Clinical Labs Ltd
 Mar 21, 2023 HOLD Hold
+30.4% avg upside
6 analysts
$3.30
50.03% Upside
 ·
AU:IDX
Integral Diagnostics Ltd.
 Feb 17, 2023 BUY Strong Buy
+59.2% avg upside
12 analysts
$3.30
67.72% Upside
 ·
SKHHY
Sonic Healthcare
 Jul 17, 2021 HOLD Buy
5 analysts
 — -20.1%
CSLLY
CSL
 Mar 24, 2020 BUY Buy
+1149.6% avg upside
3 analysts
$237.44
1149.65% Upside
 +18.6%
FR:EL
EssilorLuxottica SA
 Aug 09, 2017 BUY Strong Buy
+12.2% avg upside
17 analysts
$113.66
35.94% Downside
 ·
GB:SN
Smith & Nephew
 Jul 28, 2017 BUY Strong Buy
+1311.8% avg upside
15 analysts
$112842.52
9864.09% Upside
 ·
DVA
DaVita
 Jun 26, 2017 HOLD Hold
-23.2% avg upside
17 analysts
$70.00
66.27% Downside
 +10.9%
GB:ITV
ITV plc
 Aug 05, 2016 BUY Buy
+4269.2% avg upside
11 analysts
$23089.89
28547.58% Upside
 ·
FMS
Fresenius Medical Care
 Jul 08, 2016 HOLD Buy
+97.6% avg upside
13 analysts
$81.00
243.32% Upside
 +10.8%
GB:BTRW
Barratt Redrow
 Jun 09, 2016 BUY Strong Buy
+3283.4% avg upside
7 analysts
$60108.19
22685.52% Upside
 ·
GB:EXPN
Experian
 Jun 09, 2016 BUY Buy
+283.6% avg upside
19 analysts
$111725.27
4353.00% Upside
 ·
SNN
Smith & Nephew Snats
 May 09, 2016 BUY Buy
+11.8% avg upside
14 analysts
 — +1.7%
SYK
Stryker
 Mar 07, 2016 HOLD Strong Buy
+24.1% avg upside
36 analysts
$100.00
67.58% Downside
 +27.3%
ARAY
Accuray
 Mar 03, 2016 BUY Buy
+1693.7% avg upside
9 analysts
$11.00
3061.74% Upside
 +1.7%
ZBH
Zimmer Biomet Holdings
 Feb 04, 2016 BUY Buy
+27.6% avg upside
37 analysts
$125.00
42.19% Upside
 +22.1%
🔒 22 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Chris Cooper — Frequently Asked Questions
How accurate are Chris Cooper's stock ratings?
Based on the calls 13Foresight could measure, about 82% of Chris's ratings were profitable over a one-year hold, with an average return of +9.4% per rating, or -11.0% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Chris ranked on 13Foresight?
Chris Cooper is currently ranked #483 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Chris cover?
Chris most recently has ratings on AU:PME, AU:RMD, AU:COH, RMD, AU:NAN, AU:SHL, AU:HLS, AU:CSL, AU:OPT, AU:RHC, CSL, ARCT and 15 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.